-+ 0.00%
-+ 0.00%
-+ 0.00%

William Blair Initiates Coverage On Enliven Therapeutics with Outperform Rating

Benzinga·08/18/2026 12:57:32
Listen to the news
William Blair analyst Andy Hsieh initiates coverage on Enliven Therapeutics (NASDAQ:ELVN) with a Outperform rating.